FDA Doesn't Have To Release Provenge Docs: 2nd Circ.
A three-judge panel for the U.S. Court of Appeals for the Second Circuit ruled that a district court did not abuse its discretion when it granted the FDA summary judgment and denied CareToLive leave to conduct discovery.
CareToLive, which focuses on treatment for prostate cancer patients, first launched the suit...
Already a subscriber? Click here to login